ArticleSensors (Basel, Switzerland)2024
TW-YOLO: An Innovative Blood Cell Detection Model Based on Multi-Scale Feature Fusion.
Article in Sensors (Basel, Switzerland), 2024. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 6 papers.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
6 citing papers in PubMed.
- Deep Learning-Based Detection Model for Leukemia Cells in Peripheral Blood Smears Using YOLOv11-Large.Current oncology (Toronto, Ont.) · 2026Article
- MRR-YOLO: an instance segmentation technique for ground-based cloud images.Scientific reports · 2026Article
- CA-YOLO: An Efficient YOLO-Based Algorithm with Context-Awareness and Attention Mechanism for Clue Cell Detection in Fluorescence Microscopy Images.Sensors (Basel, Switzerland) · 2025Article
- Multiscale deformed attention networks for white blood cell detection.Scientific reports · 2025Article
- A two stage blood cell detection and classification algorithm based on improved YOLOv7 and EfficientNetv2.Scientific reports · 2025Article
- Application research on YOLOv5 model based on Lightweight Atrous Attention Module in brain tumor MRI image segmentation.Frontiers in medicine · 2025Article
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
5 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
As deep learning technology has progressed, automated medical image analysis is becoming ever more crucial in clinical diagnosis. However, due to the diversity and complexity of blood cell images, traditional models still exhibit deficiencies in blood cell detection. To address blood cell detection, we developed the TW-YOLO approach, leveraging multi-scale feature fusion techniques. Firstly, traditional CNN (Convolutional Neural Network) convolution has poor recognition capabilities for certain blood cell features, so the RFAConv (Receptive Field Attention Convolution) module was incorporated into the backbone of the model to enhance its capacity to extract geometric characteristics from blood cells. At the same time, utilizing the feature pyramid architecture of YOLO (You Only Look Once), we enhanced the fusion of features at different scales by incorporating the CBAM (Convolutional Block Attention Module) in the detection head and the EMA (Efficient Multi-Scale Attention) module in the neck, thereby improving the recognition ability of blood cells. Additionally, to meet the specific needs of blood cell detection, we designed the PGI-Ghost (Programmable Gradient Information-Ghost) strategy to finely describe the gradient flow throughout the process of extracting features, further improving the model's effectiveness. Experiments on blood cell detection datasets such as BloodCell-Detection-Dataset (BCD) reveal that TW-YOLO outperforms other models by 2%, demonstrating excellent performance in the task of blood cell detection. In addition to advancing blood cell image analysis research, this work offers strong technical support for future automated medical diagnostics.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.